The Veterinary Record Link to Vetlife website
HOME CURRENT ISSUE TABLE OF CONTENTS ARCHIVE SEARCH SUBSCRIPTIONS JOBS FEEDBACK HELP
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergman, J. G. H. E.
Right arrow Articles by Paul, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bergman, J. G. H. E.
Right arrow Articles by Paul, G.
The Veterinary Record 159:733-736 (2006)
© 2006 British Veterinary Association


Papers and Articles

Comparative trial of the canine parvovirus, canine distemper virus and canine adenovirus type 2 fractions of two commercially available modified live vaccines

J. G. H. E. Bergman, DVM1, M. Muniz, DVM1, D. Sutton, BVetMed, MRCVS1, R. Fensome1, F. Ling, BSc, PhD1 and G. Paul, DVM, PhD2

1 Intervet UK, Walton Manor, Milton Keynes MK7 7AJ
2 Intervet International, Wim de Körverstraat 35, PO Box 31, 5830AA Boxmeer, The Netherlands

The results of vaccinating two groups of puppies with commercial vaccines, both of which claimed to provide adequate protection with a final vaccination at 10 weeks of age, were compared. Groups of 19 and 20 puppies with similar titres of maternally derived antibodies against canine parvovirus (CPV), canine distemper virus (CDV) and canine adenovirus type 2 (CAV-2) at four weeks of age were vaccinated at six and 10 weeks of age and their responses to each vaccination were measured by comparing the titres against CPV, CDV and CAV-2 in the serum samples taken immediately before the vaccination and four weeks later. After the vaccination at six weeks of age, all 19 of the puppies in group 1 had responded to CPV and CDV, and 14 had responded to CAV-2; in group 2, 17 of the 20 had responded to CPV, 19 to CDV and 15 to CAV-2. In both groups the puppies that did not respond to the first vaccination had responded serologically to CPV, CDV and CAV-2 at 10 weeks of age.




This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
E. N. T. Meeusen, J. Walker, A. Peters, P.-P. Pastoret, and G. Jungersen
Current Status of Veterinary Vaccines
Clin. Microbiol. Rev., July 1, 2007; 20(3): 489 - 510.
[Abstract] [Full Text] [PDF]


Home page
Vet Rec.Home page
M. Atkinson
Canine parvovirus vaccination
Vet Rec., December 23, 2006; 159(26): 895 - 895.
[Full Text] [PDF]


Home page
Vet Rec.Home page
J. G. H. E. Bergman
Canine parvovirus vaccination
Vet Rec., December 23, 2006; 159(26): 895 - 896.
[Full Text] [PDF]




HOME CURRENT ISSUE TABLE OF CONTENTS ARCHIVE SEARCH SUBSCRIPTIONS JOBS FEEDBACK HELP
Copyright © 2006 British Veterinary Association